Pharmaceutical composition for use in the treatment of hepatitis B virus infection or co-infection
Described are pharmaceutical compositions for use in the treatment of hepatitis B virus infection or co-infection in an adult human patient for once a day administration, comprising from 0.5 mg to 1.0 mg of entecavir adhered to a pharmaceutically acceptable carrier substrate. Described are pharmaceu...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; slo |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | Described are pharmaceutical compositions for use in the treatment of hepatitis B virus infection or co-infection in an adult human patient for once a day administration, comprising from 0.5 mg to 1.0 mg of entecavir adhered to a pharmaceutically acceptable carrier substrate.
Described are pharmaceutical compositions for use in the treatment of hepatitis B virus infection or co-infection in an adult human patient for once a day administration, comprising from 0.5 mg to 1.0 mg of entecavir adhered to a pharmaceutically acceptable carrier substrate. |
|---|